Healthcare U.S. Pharmacogenomics Markets

 

INDUSTRY
Healthcare

RELEASE DATE
06-Jun-2001
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
7965-01-00-00-00
SKU
HC00378-NA-MR_03582
Yes
SHARE

U.S. Pharmacogenomics Markets
Published on: 06-Jun-2001 | SKU: HC00378-NA-MR_03582

Need more details?

$3,950.00

$2,962.50 save 25 %

DownloadLink
Need more details?

The U.S. Pharmacogenomics Market report focuses on the varying dynamics of the pharmacogenomics market. This report covers the Pharmacogenomics services, Gene-based Diagnostics, and Orphan Drugs segments. This report provides an in-depth analysis of the revenue sales forecasts for the market, drivers and restraints that affect the current and future markets, industry challenges and strategies, competitive, pricing and demand analysis and market and technology trends. The base year for this report is 2000.

Market Overview

  • Pharmacogenomics and Polymorphisms
  • The Advantages of Pharmacogenomics
  • Market for Pharmacogenomics

Analysis by Major Segments

  • Overview
  • Service Market of Pharmacogenomics
  • Diagnostics
  • Orphan Drugs
  • Overall Trends
  • Competitive Analysis
  • Technologies

Research and Scope

Methodology and Definitions

  • Objectives and Validation
  • Structure and Segmentation
  • Forecast Period - Milestones

Total Market Analysis

  • Research Methodology
  • List of Definitions
  • List of Acronyms

Conclusion

  • Market Overview
  • Market Challenges
  • Market Drivers
  • Market Restraints
  • Market Forecast

Market Engineering Awards

  • Recommendations
  • Concluding Remarks

Service Market

Microarrays Market

Bioinformatics Market

Present Status of Diagnostics in Pharmacogenomics

Future Status for Diagnostics in Pharmacogenomics

Background

The Present Market for Orphan Drugs

The Future for Orphan Drugs


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

26 Aug 2026   |   Global   |   Technology Research

Growth Opportunities and Advancements in Acute and Chronic Wound Care

A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...

26 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026

Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The U.S. Pharmacogenomics Market report focuses on the varying dynamics of the pharmacogenomics market. This report covers the Pharmacogenomics services, Gene-based Diagnostics, and Orphan Drugs segments. This report provides an in-depth analysis of the revenue sales forecasts for the market, drivers and restraints that affect the current and future markets, industry challenges and strategies, competitive, pricing and demand analysis and market and technology trends. The base year for this report is 2000.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Industries Healthcare
WIP Number 7965-01-00-00-00
Is Prebook No

U.S. Pharmacogenomics Markets

$3,950.00

Special Price $2,962.50 save 25 %

In stock
SKU
HC00378-NA-MR_03582